It has been incorrectly suggested that Bill C-393’s “one-licence solution” does not comply with Canada’s WTO obligations. Complementing the Legal Network’s earlier brief, this document outlines in summary form the key issues and the provisions of WTO law that permit Canada to simplify the current CAMR as proposed by Bill C-393, while complying with its … Read more
“We, the undersigned civil society organizations, write to you regarding intellectual property provisions in the proposed Trans-Pacific Partnership Agreement (TPPA). We are concerned that intellectual property measures that may be included in an eventual agreement could undermine patients’ access to vital medicines, and contravene promises of a new trade model and ’21st century’ agreement.”
The campaign in Canada’s Parliament to fix Canada’s Access to Medicines Regime (CAMR) — so that more affordable live-saving medicines can get to developing countries — continues and is now at a critical juncture.